Kevin D. Bunker, Chief Operating Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 15,556 shares at $48.72 ($761K) on 2022-03-21, disclosed to the SEC on 2022-03-21.
Open-market sale of $761k ZNTL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.72 | 5,556 | $271K | 35.6% |
| 2 | $48.72 | 5,556 | $271K | 35.6% |
| 3 | $49.50 | 4,444 | $220K | 28.9% |
| Total | $48.94 avg | 15,556 | $761K | 100% |
| Filing → |
| ZNTL | SELL | 2023-02-14 | $285K | — | Filing → |
| ZNTL | SELL | 2022-08-12 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-20 | $150K | — | Filing → |